Rigel Pharmaceuticals (RIGL) Invested Capital (2023 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Invested Capital of $29.9 million for Q1 2026, up 101.59% year-over-year from $14.8 million in Q1 2025, and little changed quarter-over-quarter from $29.8 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Invested Capital (2023 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Invested Capital history runs 4 years deep, the most recent figure standing at $29.9 million for Q1 2026.
- In Q1 2026, Invested Capital rose 101.59% year-over-year to $29.9 million; the TTM figure through Mar 2026 stood at $111.8 million (up 406.18% YoY), while the FY2025 annual figure was $29.8 million, up 309.96% from the prior year.
- Invested Capital for Q1 2026 stood at $29.9 million, roughly flat from $29.8 million in the prior quarter.
- The five-year high for Invested Capital was $29.9 million in Q1 2026, with the low at $7.2 million in Q4 2023.
- The 4-year median for Invested Capital is $18.6 million (2025), against an average of $19.5 million.
- Peak annual rise in Invested Capital reached 309.96% in 2025, while the deepest fall reached 0.24% in 2025.
- Rigel Pharmaceuticals' Invested Capital stood at $7.2 million in 2023, then advanced by 0.59% to $7.3 million in 2024, then soared by 309.96% to $29.8 million in 2025, then advanced by 0.18% to $29.9 million in 2026.
- Business Quant data shows RIGL's Invested Capital at $29.9 million in Q1 2026, $29.8 million in Q4 2025, and $29.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | 39.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.24 Mn |
| Mar 31, 2026 | 29.87 Mn |
| Dec 31, 2025 | 29.81 Mn |
| Sep 30, 2025 | 29.76 Mn |
| Jun 30, 2025 | 22.36 Mn |
| Mar 31, 2025 | 14.82 Mn |
| Dec 31, 2024 | 7.27 Mn |
| Mar 31, 2024 | 14.78 Mn |
| Dec 31, 2023 | 7.23 Mn |